Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-06 Sale |
2025-01-08 4:23 pm |
Entero Therapeutics Inc. | ENTO | Romano Sarah Chief Financial Officer |
727 | $0.64 | $465 | 17,287 (Direct) |
View |
| 2024-10-09 Sale |
2024-10-10 5:00 pm |
Entero Therapeutics Inc. | ENTO | Romano Sarah Chief Financial Officer |
476 | $0.446 | $212 | 18,014 (Direct) |
View |
| 2024-07-02 Sale |
2024-07-03 2:34 pm |
Entero Therapeutics Inc. | ENTO | Romano Sarah Chief Financial Officer |
621 | $1.07 | $664 | 18,490 (Direct) |
View |
| 2024-04-01 Sale |
2024-04-03 5:13 pm |
First Wave BioPharma Inc. | FWBI | Romano Sarah Chief Financial Officer |
75 | $4.2294 | $317 | 19,111 (Direct) |
View |
| 2024-03-15 Sale |
2024-03-19 4:10 pm |
First Wave BioPharma Inc. | FWBI | Romano Sarah Chief Financial Officer |
1,120 | $4.96 | $5,555 | 19,186 (Direct) |
View |
| 2024-01-12 Sale |
2024-01-17 4:02 pm |
First Wave BioPharma Inc. | FWBI | Romano Sarah Chief Financial Officer |
98 | $4.2 | $412 | 20,306 (Direct) |
View |
| 2023-10-04 Sale |
2023-10-06 4:05 pm |
First Wave BioPharma Inc. | FWBI | Romano Sarah Chief Financial Officer |
1,676 | $0.29 | $486 | 15,800 (Direct) |
View |
| 2023-07-03 Sale |
2023-07-05 4:28 pm |
First Wave BioPharma Inc. | FWBI | Romano Sarah Chief Financial Officer |
1,977 | $1.54 | $3,045 | 17,476 (Direct) |
View |
| 2023-04-03 Sale |
2023-04-05 4:17 pm |
First Wave BioPharma Inc. | FWBI | Romano Sarah Chief Financial Officer |
1,975 | $2.5 | $4,938 | 19,453 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2025-04-11 7:10 pm |
N/A 2036-04-10 |
Vicarious Surgical Inc. | RBOT | Romano Sarah Chief Financial Officer |
0 | $0 | 55,000 (Direct) |
View |
| 2023-12-29 Option Award |
2024-01-03 7:54 pm |
N/A N/A |
First Wave BioPharma Inc. | FWBI | Romano Sarah Chief Financial Officer |
19,614 | $0 | 20,404 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 09:01 am |
N/A N/A |
First Wave BioPharma Inc. | FWBI | Romano Sarah Chief Financial Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-02 6:02 pm |
N/A 2032-03-01 |
First Wave BioPharma Inc. | FWBI | Romano Sarah Chief Financial Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-11 4:31 pm |
N/A N/A |
KIORA PHARMACEUTICALS INC | KPRX | Romano Sarah Chief Financial Officer |
108 | $0.69 | 22,746 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 7:06 pm |
N/A 2032-02-01 |
KIORA PHARMACEUTICALS INC | KPRX | Romano Sarah Chief Financial Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-01-05 Tax Withholding |
2022-01-06 5:10 pm |
N/A N/A |
KIORA PHARMACEUTICALS INC | KPRX | Romano Sarah Chief Financial Officer |
114 | $1.08 | 22,854 (Direct) |
View |
| 2021-12-07 Tax Withholding |
2021-12-08 4:15 pm |
N/A N/A |
KIORA PHARMACEUTICALS INC | KPRX | Romano Sarah Chief Financial Officer |
91 | $1.3 | 22,968 (Direct) |
View |
| 2021-11-02 Tax Withholding |
2021-11-03 4:15 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
83 | $1.98 | 23,059 (Direct) |
View |
| 2021-10-04 Tax Withholding |
2021-10-05 6:40 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
83 | $2.01 | 23,142 (Direct) |
View |
| 2021-09-02 Tax Withholding |
2021-09-03 4:16 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
84 | $1.81 | 23,225 (Direct) |
View |
| 2021-08-03 Tax Withholding |
2021-08-04 5:45 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
87 | $2.4 | 23,309 (Direct) |
View |
| 2021-07-02 Tax Withholding |
2021-07-06 4:32 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
180 | $3.7 | 23,396 (Direct) |
View |
| 2021-06-04 Tax Withholding |
2021-06-07 5:02 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
180 | $4.19 | 23,576 (Direct) |
View |
| 2021-05-04 Tax Withholding |
2021-05-05 9:57 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
177 | $4.13 | 23,756 (Direct) |
View |
| 2021-04-08 Tax Withholding |
2021-04-09 4:16 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
180 | $4.94 | 23,933 (Direct) |
View |
| 2021-03-03 Tax Withholding |
2021-03-05 4:31 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
218 | $5.46 | 24,113 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-03 9:53 pm |
N/A 2031-02-01 |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
30,000 | $0 | 54,331 (Direct) |
View |
| 2021-02-02 Tax Withholding |
2021-02-03 9:53 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
1,282 | $6.34 | 54,331 (Direct) |
View |
| 2021-01-04 Tax Withholding |
2021-01-05 4:16 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
115 | $4.85 | 25,613 (Direct) |
View |
| 2020-12-07 Tax Withholding |
2020-12-08 8:16 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
91 | $3.76 | 25,728 (Direct) |
View |
| 2020-11-02 Tax Withholding |
2020-11-03 4:15 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
97 | $3.51 | 25,819 (Direct) |
View |
| 2020-10-02 Tax Withholding |
2020-10-05 5:57 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
98 | $3.88 | 25,916 (Direct) |
View |
| 2020-09-02 Tax Withholding |
2020-09-03 5:30 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
97 | $3.94 | 26,014 (Direct) |
View |
| 2020-08-04 Tax Withholding |
2020-08-05 5:12 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
95 | $4.11 | 26,111 (Direct) |
View |
| 2020-07-02 Tax Withholding |
2020-07-06 4:15 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
97 | $4.82 | 26,206 (Direct) |
View |
| 2020-06-03 Tax Withholding |
2020-06-04 4:17 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
94 | $5.11 | 26,303 (Direct) |
View |
| 2020-05-05 Tax Withholding |
2020-05-06 4:31 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
93 | $5.1 | 26,397 (Direct) |
View |